On January 30, 2019, Gary Lyons submitted his resignation as a member of the Board of Directors of Cytori Therapeutics, Inc. effective immediately, and the Board of Directors decreased its size from five to four members. Mr. Lyons’s decision to resign did not result from any disagreement with the Company concerning any matter relating to the Company’s operations, policies or practices.